Day: December 10, 2021

Junshi Biosciences Announces NMPA Accepted supplemental New Drug Application for Toripalimab in Combination with Chemotherapy as First-Line Treatment of Advanced NSCLC

6th indication for toripalimab submitted in China SHANGHAI, China, Dec. 10, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (the “NMPA”) has accepted the company’s

Read more

Myanmar anti-coup activists protest against junta with ‘silent strike’

Published by Reuters (Reuters) – Protesters in Myanmar closed businesses and stayed off the streets on Friday in a “silent strike” against rule by the military and its ousting of the Southeast Asian country’s democratically elected government in a February coup. Photos published by Myanmar media showed deserted streets and

Read more

Spend Matters Secures Investment From Copley Equity Partners

Proceeds to Fund Continued Growth in Procurement While Expanding into Adjacent Markets BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Copley Equity Partners, LLC (“Copley”), a private investment firm focused on lower middle-market companies with strong growth opportunities, today announced that it has made an investment in Spend Matters, a proprietary

Read more

Imperial Capital Opens Authorized European Company in Milan, Italy to Conduct European Business and Names Julien Sida as its CEO

LOS ANGELES, Dec. 09, 2021 (GLOBE NEWSWIRE) — Imperial Capital Group, LLC (“Imperial Capital”) announced that its affiliate, Imperial Capital (International) LLP (“Imperial Capital International”), has completed the process of transitioning its Milan Branch into an authorized subsidiary amidst the end of the Brexit transition period whereby passporting between the

Read more

Recent News